Advertisement
MCRPF vs NNCSF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRPF is a Hold and NNCSF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MCRPF’s FA Score shows that 1 FA rating(s) are green whileNNCSF’s FA Score has 0 green FA rating(s).
- MCRPF’s FA Score: 1 green, 4 red.
- NNCSF’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MCRPF’s TA Score shows that 2 TA indicator(s) are bullish while NNCSF’s TA Score has 3 bullish TA indicator(s).
- MCRPF’s TA Score: 2 bullish, 3 bearish.
- NNCSF’s TA Score: 3 bullish, 5 bearish.
Price Growth
MCRPF (@Medical/Nursing Services) experienced а 0.00% price change this week, while NNCSF (@Pharmaceuticals: Other) price change was -14.75% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.15%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +24.88%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.55%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was +18.40%.
Industries' Descriptions
@Medical/Nursing Services (-0.15% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-1.55% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| MCRPF | NNCSF | MCRPF / NNCSF | |
| Capitalization | 3.24B | 807M | 401% |
| EBITDA | N/A | 28.2M | - |
| Gain YTD | 93.902 | 23.810 | 394% |
| P/E Ratio | N/A | 59.63 | - |
| Revenue | N/A | 186M | - |
| Total Cash | N/A | N/A | - |
| Total Debt | N/A | N/A | - |
MCRPF | NNCSF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 92 | 94 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 72 | |
PRICE GROWTH RATING 1..100 | 37 | 52 | |
P/E GROWTH RATING 1..100 | 2 | 74 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCRPF's Valuation (86) in the null industry is in the same range as NNCSF (98). This means that MCRPF’s stock grew similarly to NNCSF’s over the last 12 months.
MCRPF's Profit vs Risk Rating (100) in the null industry is in the same range as NNCSF (100). This means that MCRPF’s stock grew similarly to NNCSF’s over the last 12 months.
NNCSF's SMR Rating (72) in the null industry is in the same range as MCRPF (96). This means that NNCSF’s stock grew similarly to MCRPF’s over the last 12 months.
MCRPF's Price Growth Rating (37) in the null industry is in the same range as NNCSF (52). This means that MCRPF’s stock grew similarly to NNCSF’s over the last 12 months.
MCRPF's P/E Growth Rating (2) in the null industry is significantly better than the same rating for NNCSF (74). This means that MCRPF’s stock grew significantly faster than NNCSF’s over the last 12 months.
| MCRPF | NNCSF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 45% | 2 days ago 56% |
| Stochastic ODDS (%) | 2 days ago 57% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 58% | 2 days ago 40% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 46% |
| TrendWeek ODDS (%) | 2 days ago 49% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 66% | 2 days ago 43% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | N/A | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 63% | 2 days ago 43% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBPYX | 43.02 | 0.61 | +1.44% |
| ClearBridge Small Cap Growth I | |||
| FNGZX | 18.03 | 0.21 | +1.18% |
| Franklin Intl Growth Adv | |||
| FSTBX | 22.14 | 0.13 | +0.59% |
| Federated Hermes Global Allocation A | |||
| JDDVX | 12.92 | 0.07 | +0.54% |
| Janus Henderson U.S. Dividend Income D | |||
| EQPGX | 25.50 | N/A | N/A |
| Fidelity Advisor Equity Growth I | |||
MCRPF and
Correlation & Price change
A.I.dvisor tells us that MCRPF and LDDD have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCRPF and LDDD's prices will move in lockstep.
| Ticker / NAME | Correlation To MCRPF | 1D Price Change % | ||
|---|---|---|---|---|
| MCRPF | 100% | N/A | ||
| LDDD - MCRPF | 21% Poorly correlated | N/A | ||
| NHNKF - MCRPF | 1% Poorly correlated | N/A | ||
| NNCSF - MCRPF | 1% Poorly correlated | N/A | ||
| MRCHF - MCRPF | -0% Poorly correlated | N/A | ||
| MDRSF - MCRPF | -0% Poorly correlated | N/A | ||
More | ||||
NNCSF and
Correlation & Price change
A.I.dvisor tells us that NNCSF and MBGNF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and MBGNF's prices will move in lockstep.
| Ticker / NAME | Correlation To NNCSF | 1D Price Change % | ||
|---|---|---|---|---|
| NNCSF | 100% | N/A | ||
| MBGNF - NNCSF | 23% Poorly correlated | N/A | ||
| NHNKY - NNCSF | 8% Poorly correlated | +0.48% | ||
| NVYTF - NNCSF | 7% Poorly correlated | N/A | ||
| POCI - NNCSF | 1% Poorly correlated | -0.20% | ||
| MCRPF - NNCSF | 1% Poorly correlated | N/A | ||
More | ||||